Phase IIb Multi-Center Randomised Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment with GSK3228836 in Participants with Chronic Hepatitis B Virus (B-Clear)
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
